首页 > 最新文献

Science Progress最新文献

英文 中文
A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri). 一项真实世界的回顾性队列研究,比较了品牌非布司他(feburic)和非布司他(feuri)。
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-03-10 DOI: 10.1177/00368504261433091
Shang-Feng Tsai, Ming-Ju Wu, Cheng-Hsu Chen

ObjectiveTo compare the effectiveness, safety, and cost outcomes of brand-name febuxostat (feburic) and generic febuxostat (feuri) in patients with hyperuricemia or gout in a real-world clinical setting.MethodsWe conducted a retrospective cohort study using electronic medical records from Taichung Veterans General Hospital between November 2021 and December 2023. Adult patients with hyperuricemia or gout who initiated febuxostat therapy and had no prior urate-lowering treatment in the preceding 3 months were included. Serum uric acid levels were assessed at baseline, 3 months, and the final follow-up. Propensity score matching (1:1) was applied to balance baseline demographic, clinical, laboratory, cardiovascular, and renal characteristics. Clinical outcomes, laboratory parameters, and medication costs were compared between groups.ResultsBoth feuri and feburic were associated with significant reductions in serum uric acid levels after 3 months of treatment. At the 3-month assessment, the mean serum uric acid level was modestly lower in the feuri group (5.41 ± 2.06 mg/dL) than in the feburic group (5.75 ± 2.12 mg/dL; P = .001). At the final follow-up, serum uric acid levels remained numerically lower in the feuri group, although the difference was not statistically significant (P = .07). The feuri group was prescribed a lower final daily dose, which was associated with lower annual medication costs. The proportions of patients achieving recommended uric acid goals were similar between groups, suggesting broadly comparable clinical effectiveness in routine practice. After propensity score matching (n = 486 pairs), no significant differences were observed between groups in cardiovascular, renal, or overall safety outcomes.ConclusionsThis real-world study suggests that generic febuxostat is associated with safety outcomes comparable to those of the brand-name formulation and may be prescribed at lower doses and lower medication costs in routine clinical practice.

目的比较品牌非布司他(feburic)和非布司他(feuri)在高尿酸血症或痛风患者中的有效性、安全性和成本结果。方法采用台中退伍军人总医院2021年11月至2023年12月的电子病历进行回顾性队列研究。接受非布司他治疗且在前3个月内未接受降尿酸治疗的高尿酸血症或痛风成年患者被纳入研究。在基线、3个月和最后随访时评估血清尿酸水平。倾向评分匹配(1:1)用于平衡基线人口统计学、临床、实验室、心血管和肾脏特征。比较两组患者的临床结果、实验室参数和用药费用。结果治疗3个月后,feuri和feic均与血清尿酸水平显著降低相关。在3个月的评估中,feuric组的平均血清尿酸水平(5.41±2.06 mg/dL)略低于feuric组(5.75±2.12 mg/dL, P = .001)。在最后的随访中,尽管差异无统计学意义(P = .07),但feuri组的血清尿酸水平仍在数值上较低。feuri组的最终每日剂量较低,这与较低的年度药物费用相关。达到推荐尿酸目标的患者比例在两组之间相似,表明在常规实践中临床效果大致相当。在倾向评分匹配(n = 486对)后,两组在心血管、肾脏或总体安全结局方面没有观察到显著差异。结论:这项现实世界的研究表明,非布司他仿制药的安全性与品牌制剂相当,并且可以在常规临床实践中以更低的剂量和更低的药物成本开处方。
{"title":"A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri).","authors":"Shang-Feng Tsai, Ming-Ju Wu, Cheng-Hsu Chen","doi":"10.1177/00368504261433091","DOIUrl":"https://doi.org/10.1177/00368504261433091","url":null,"abstract":"<p><p>ObjectiveTo compare the effectiveness, safety, and cost outcomes of brand-name febuxostat (feburic) and generic febuxostat (feuri) in patients with hyperuricemia or gout in a real-world clinical setting.MethodsWe conducted a retrospective cohort study using electronic medical records from Taichung Veterans General Hospital between November 2021 and December 2023. Adult patients with hyperuricemia or gout who initiated febuxostat therapy and had no prior urate-lowering treatment in the preceding 3 months were included. Serum uric acid levels were assessed at baseline, 3 months, and the final follow-up. Propensity score matching (1:1) was applied to balance baseline demographic, clinical, laboratory, cardiovascular, and renal characteristics. Clinical outcomes, laboratory parameters, and medication costs were compared between groups.ResultsBoth feuri and feburic were associated with significant reductions in serum uric acid levels after 3 months of treatment. At the 3-month assessment, the mean serum uric acid level was modestly lower in the feuri group (5.41 ± 2.06 mg/dL) than in the feburic group (5.75 ± 2.12 mg/dL; <i>P</i> = .001). At the final follow-up, serum uric acid levels remained numerically lower in the feuri group, although the difference was not statistically significant (<i>P</i> = .07). The feuri group was prescribed a lower final daily dose, which was associated with lower annual medication costs. The proportions of patients achieving recommended uric acid goals were similar between groups, suggesting broadly comparable clinical effectiveness in routine practice. After propensity score matching (<i>n</i> = 486 pairs), no significant differences were observed between groups in cardiovascular, renal, or overall safety outcomes.ConclusionsThis real-world study suggests that generic febuxostat is associated with safety outcomes comparable to those of the brand-name formulation and may be prescribed at lower doses and lower medication costs in routine clinical practice.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261433091"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies to optimize bowel preparation quality for colonoscopy in individuals. 优化个人结肠镜检查肠道准备质量的策略。
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-03-07 DOI: 10.1177/00368504251412984
Youping Wang, Mingkai Chen, Xin Gao

Colorectal cancer remains a major global health concern, highlighting the critical importance of effective colonoscopy, whose success depends on high-quality bowel preparation. Inadequate preparation is common and leads to prolonged procedure, and missed polyps and adenomas. It is important to recognize that not all individuals can attain adequate bowel preparation through a uniform regimen. Various risk factors influencing bowel preparation quality have been reported, and different laxative regimens each present distinct advantages and limitations. Understanding these elements can help improve patient bowel preparation outcomes. This is a narrative review. This article attempts to summarize available clinical trials and evidence regarding strategies to optimize bowel preparation for individuals.

结直肠癌仍然是一个主要的全球健康问题,强调了有效结肠镜检查的重要性,其成功取决于高质量的肠道准备。准备不足是常见的,导致手术时间延长,漏诊息肉和腺瘤。重要的是要认识到,并非所有人都能通过统一的方案获得充分的肠道准备。影响肠道准备质量的各种危险因素已被报道,不同的泻药方案各有其独特的优点和局限性。了解这些因素有助于改善患者的肠道准备结果。这是一个叙述性的回顾。本文试图总结现有的临床试验和证据的策略,以优化肠道准备的个人。
{"title":"Strategies to optimize bowel preparation quality for colonoscopy in individuals.","authors":"Youping Wang, Mingkai Chen, Xin Gao","doi":"10.1177/00368504251412984","DOIUrl":"10.1177/00368504251412984","url":null,"abstract":"<p><p>Colorectal cancer remains a major global health concern, highlighting the critical importance of effective colonoscopy, whose success depends on high-quality bowel preparation. Inadequate preparation is common and leads to prolonged procedure, and missed polyps and adenomas. It is important to recognize that not all individuals can attain adequate bowel preparation through a uniform regimen. Various risk factors influencing bowel preparation quality have been reported, and different laxative regimens each present distinct advantages and limitations. Understanding these elements can help improve patient bowel preparation outcomes. This is a narrative review. This article attempts to summarize available clinical trials and evidence regarding strategies to optimize bowel preparation for individuals.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251412984"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12967346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-specific prevalence and genotype distribution of male HPV infection in Jinshan District, Shanghai, China: A single-center cross-sectional study. 中国上海金山区男性HPV感染的年龄特异性患病率和基因型分布:一项单中心横断面研究
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-02-04 DOI: 10.1177/00368504261420927
Shanshan Chen, Jing Chen, Tao Xiao

ObjectiveTo estimate the prevalence of human papillomavirus (HPV) infection among males in Jinshan District, Shanghai, China.MethodsStudy design: single-center, retrospective cross-sectional study.

Setting: Tinglin Hospital, Jinshan District, Shanghai, China.

Participants: 116 males aged 22-71 years from outpatient, inpatient, and routine physical examination settings.

Outcomes: overall HPV prevalence, age-specific prevalence, and genotype distribution (high-risk and low-risk).ResultsWe first describe the overall and age-specific prevalence, followed by genotype distribution and the pattern of single versus multiple infections. A total of 116 males aged 22 to 71 years old were enrolled for investigation. The overall HPV infection rate was 31.90% (37/116). The infection rates of different HPV subtypes in various age groups were listed as follows: 12% (3/25) for the 22-30 age group, 27.59% (8/29) for the 31-40 age group, 50% (18/36) for the 41-50 age group, 16.67% (3/18) for the 51-60 age group, and 62.5% (5/8) for the over 60 age group. Among the infected individuals, 27 out of 116 (23.28%) suffered from single subtype infections, while 8 individuals (6.90%) endured dual infections, and 2 individuals (1.72%) had three or more subtypes detected. High-risk HPVs accounted for 30.17%, with the highest infection rates observed in HPVs including HPV-53, HPV-58, HPV-52, HPV-16, and HPV-31. In comparison, low-risk HPVs accounted for 12.93%, with the highest infection rates seen in HPVs including HPV-6, HPV-81, and HPV-11. Apart from that, HPVs such as HPV-18, HPV-59, HPV-73, HPV-70 and HPV-83 were not detected in any of the specimens.ConclusionMales are predominantly infected with a single-subtype HPV infection. The infection rate is highest in the age group of 60 and above, while the infection rate is the lowest in the age group of 22-30 years. It is essential to formulate corresponding strategies and screening plans for the elderly over 60 years to lower or prevent the risk of HPV infection.

目的了解上海市金山区男性人乳头瘤病毒(HPV)感染情况。方法研究设计:单中心、回顾性横断面研究。单位:上海市金山区亭林医院。参与者:116名男性,年龄22-71岁,来自门诊、住院和常规体检机构。结果:总体HPV患病率、年龄特异性患病率和基因型分布(高风险和低风险)。结果我们首先描述了总体和年龄特异性患病率,然后描述了基因型分布和单次与多次感染的模式。共招募了116名年龄在22 ~ 71岁之间的男性进行调查。HPV总感染率为31.90%(37/116)。各年龄组HPV不同亚型的感染率分别为:22-30岁12%(3/25),31-40岁27.59%(8/29),41-50岁50%(18/36),51-60岁16.67%(3/18),60岁以上62.5%(5/8)。116例感染者中有27例(23.28%)为单亚型感染,8例(6.90%)为双亚型感染,2例(1.72%)为三种及以上亚型感染。高危hpv占30.17%,其中HPV-53、HPV-58、HPV-52、HPV-16和HPV-31感染率最高。相比之下,低风险hpv占12.93%,HPV-6、HPV-81和HPV-11的感染率最高。此外,所有样本均未检出HPV-18、HPV-59、HPV-73、HPV-70和HPV-83等hpv。结论男性以单亚型HPV感染为主。60岁及以上年龄组感染率最高,22-30岁年龄组感染率最低。为降低或预防60岁以上老年人感染HPV的风险,制定相应的策略和筛查计划至关重要。
{"title":"Age-specific prevalence and genotype distribution of male HPV infection in Jinshan District, Shanghai, China: A single-center cross-sectional study.","authors":"Shanshan Chen, Jing Chen, Tao Xiao","doi":"10.1177/00368504261420927","DOIUrl":"10.1177/00368504261420927","url":null,"abstract":"<p><p>ObjectiveTo estimate the prevalence of human papillomavirus (HPV) infection among males in Jinshan District, Shanghai, China.MethodsStudy design: single-center, retrospective cross-sectional study.</p><p><strong>Setting: </strong>Tinglin Hospital, Jinshan District, Shanghai, China.</p><p><strong>Participants: </strong>116 males aged 22-71 years from outpatient, inpatient, and routine physical examination settings.</p><p><strong>Outcomes: </strong>overall HPV prevalence, age-specific prevalence, and genotype distribution (high-risk and low-risk).ResultsWe first describe the overall and age-specific prevalence, followed by genotype distribution and the pattern of single versus multiple infections. A total of 116 males aged 22 to 71 years old were enrolled for investigation. The overall HPV infection rate was 31.90% (37/116). The infection rates of different HPV subtypes in various age groups were listed as follows: 12% (3/25) for the 22-30 age group, 27.59% (8/29) for the 31-40 age group, 50% (18/36) for the 41-50 age group, 16.67% (3/18) for the 51-60 age group, and 62.5% (5/8) for the over 60 age group. Among the infected individuals, 27 out of 116 (23.28%) suffered from single subtype infections, while 8 individuals (6.90%) endured dual infections, and 2 individuals (1.72%) had three or more subtypes detected. High-risk HPVs accounted for 30.17%, with the highest infection rates observed in HPVs including HPV-53, HPV-58, HPV-52, HPV-16, and HPV-31. In comparison, low-risk HPVs accounted for 12.93%, with the highest infection rates seen in HPVs including HPV-6, HPV-81, and HPV-11. Apart from that, HPVs such as HPV-18, HPV-59, HPV-73, HPV-70 and HPV-83 were not detected in any of the specimens.ConclusionMales are predominantly infected with a single-subtype HPV infection. The infection rate is highest in the age group of 60 and above, while the infection rate is the lowest in the age group of 22-30 years. It is essential to formulate corresponding strategies and screening plans for the elderly over 60 years to lower or prevent the risk of HPV infection.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261420927"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12873103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential impact of public health care denial on the transmission dynamics of COVID-19 in South Africa. 拒绝提供公共医疗服务对COVID-19在南非传播动态的潜在影响
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-01-14 DOI: 10.1177/00368504251395189
Maureen Juga, Farai Nyabadza

When the demand for public health care increases, governments often prioritize citizens over foreign nationals. In South Africa, limited resources and socio-economic inequalities pose unique challenges to epidemic control. The overcrowding and increasing demand for public healthcare have led to protests by some community groups, which have led to the denial of healthcare to migrants. Denying treatment to some infected individuals has the propensity to lead to an increase in the size of an epidemic. We introduce a novel epidemiological model that incorporates health care denial as a dynamic factor influencing the transmission of COVID-19. It incorporates healthcare denial as a key parameter influencing the progression and recovery rates of infections. The study presents a novel framework for understanding the intersection of healthcare access denial and the transmission dynamics of COVID-19. While much of the existing literature has focused on the direct effects of healthcare interventions on pandemic control, this research uniquely emphasizes the role that restricted access to healthcare services, whether due to policy decisions, resource shortages, or system inefficiencies, can exacerbate the spread of infectious diseases. The treatment class of the model is partitioned to account for individuals denied treatment at public healthcare facilities. Analytical results establish conditions for the existence and stability of both disease-free and endemic equilibria, with the basic reproduction number R0 explicitly derived to quantify transmission potential under varying healthcare access scenarios. Sensitivity analysis reveals that increasing denial of care can significantly elevate R0, resulting in higher infection peaks, prolonged epidemic duration and greater cumulative mortality. Numerical simulations further illustrate the non-linear relationship between treatment accessibility and outbreak severity. The findings highlight that equitable healthcare provision is not only a public health necessity but also a critical determinant for reducing the COVID-19 burden. Policy implications stress the integration of inclusive healthcare strategies to ensure epidemic resilience and minimize transmission risks, especially in vulnerable populations. Strategies that will accommodate every infected person who goes to the hospital for treatment should be adopted to reduce the disease burden.

当对公共卫生保健的需求增加时,政府往往优先考虑本国公民而不是外国人。在南非,有限的资源和社会经济不平等对流行病的控制构成了独特的挑战。过度拥挤和对公共保健的需求不断增加导致一些社区团体的抗议,导致移徙者得不到保健服务。拒绝对某些感染者进行治疗,有可能导致流行病规模的扩大。我们引入了一种新的流行病学模型,该模型将拒绝医疗保健作为影响COVID-19传播的动态因素。它将医疗保健拒绝作为影响感染进展和恢复率的关键参数。该研究提出了一个新的框架,用于理解拒绝获得医疗保健和COVID-19传播动态的交集。虽然许多现有文献都集中在卫生保健干预对流行病控制的直接影响上,但本研究独特地强调了限制获得卫生保健服务的作用,无论是由于政策决定,资源短缺还是系统效率低下,都可能加剧传染病的传播。该模式的治疗类别进行了划分,以考虑在公共保健设施得不到治疗的个人。分析结果建立了无病平衡和地方性平衡存在和稳定的条件,明确推导了基本繁殖数R0,以量化不同医疗保健可及性情景下的传播潜力。敏感性分析表明,拒绝护理的增加可显著提高R0,导致感染高峰升高,流行持续时间延长,累积死亡率增加。数值模拟进一步说明了治疗可及性与爆发严重程度之间的非线性关系。研究结果强调,公平的医疗保健提供不仅是公共卫生的必要条件,也是减轻COVID-19负担的关键决定因素。政策影响强调整合包容性卫生保健战略,以确保流行病抵御能力并尽量减少传播风险,特别是在弱势群体中。应采取能够容纳每一个到医院接受治疗的感染者的战略,以减轻疾病负担。
{"title":"The potential impact of public health care denial on the transmission dynamics of COVID-19 in South Africa.","authors":"Maureen Juga, Farai Nyabadza","doi":"10.1177/00368504251395189","DOIUrl":"10.1177/00368504251395189","url":null,"abstract":"<p><p>When the demand for public health care increases, governments often prioritize citizens over foreign nationals. In South Africa, limited resources and socio-economic inequalities pose unique challenges to epidemic control. The overcrowding and increasing demand for public healthcare have led to protests by some community groups, which have led to the denial of healthcare to migrants. Denying treatment to some infected individuals has the propensity to lead to an increase in the size of an epidemic. We introduce a novel epidemiological model that incorporates health care denial as a dynamic factor influencing the transmission of COVID-19. It incorporates healthcare denial as a key parameter influencing the progression and recovery rates of infections. The study presents a novel framework for understanding the intersection of healthcare access denial and the transmission dynamics of COVID-19. While much of the existing literature has focused on the direct effects of healthcare interventions on pandemic control, this research uniquely emphasizes the role that restricted access to healthcare services, whether due to policy decisions, resource shortages, or system inefficiencies, can exacerbate the spread of infectious diseases. The treatment class of the model is partitioned to account for individuals denied treatment at public healthcare facilities. Analytical results establish conditions for the existence and stability of both disease-free and endemic equilibria, with the basic reproduction number <i>R</i><sub>0</sub> explicitly derived to quantify transmission potential under varying healthcare access scenarios. Sensitivity analysis reveals that increasing denial of care can significantly elevate <i>R</i><sub>0</sub>, resulting in higher infection peaks, prolonged epidemic duration and greater cumulative mortality. Numerical simulations further illustrate the non-linear relationship between treatment accessibility and outbreak severity. The findings highlight that equitable healthcare provision is not only a public health necessity but also a critical determinant for reducing the COVID-19 burden. Policy implications stress the integration of inclusive healthcare strategies to ensure epidemic resilience and minimize transmission risks, especially in vulnerable populations. Strategies that will accommodate every infected person who goes to the hospital for treatment should be adopted to reduce the disease burden.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251395189"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12804654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BUN and mortality in patients with heparin-induced thrombocytopenia: A retrospective cohort study. 肝素诱导的血小板减少症患者的BUN和死亡率:一项回顾性队列研究。
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-02-15 DOI: 10.1177/00368504261420611
Guang Tu, Zhonglan Cai, Guofeng Zhu, Min Huang

IntroductionHeparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, characterized by low platelet counts and heightened thrombotic risk. Blood urea nitrogen (BUN), which serves as an indicator of both renal function and illness severity, has been associated with poor outcomes in different contexts. However, its association with mortality in HIT remains poorly understood. Our study aimed to explore this relationship in critically ill patients with HIT.MethodsThis study was a retrospective cohort analysis utilizing the MIMIC-IV 3.1 database from 2008 to 2019. Patients with HIT were pinpointed through ICD codes. Those without BUN data or whose intensive care unit (ICU) admission was not their first were excluded. The main outcome measured was all-cause mortality, evaluated at multiple time points. The associations were examined using multivariate Cox regression models and Kaplan-Meier survival analysis.ResultsThe research encompassed 246 individuals with HIT (average age 66.2 years, 54.9% male). BUN levels showed a significant association with all-cause mortality during the hospital stay (HR 1.01, 95% CI 1.01-1.02, p = 0.001), within 30 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001), within 90 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001), and within 365 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001). Quartile analysis revealed that the highest BUN quartile (Q4) was associated with the greatest mortality risk compared to the lowest quartile (Q1) at all time points. Kaplan-Meier and restricted cubic spline analyses corroborated these results, indicating a linear relationship between BUN and mortality.ConclusionElevated BUN levels were significantly associated with higher mortality rates among HIT patients in the ICU. Monitoring BUN levels may help identify patients at greater risk and inform clinical choices. Further research is warranted to elucidate the underlying mechanisms and possible treatments.

肝素诱导的血小板减少症(HIT)是肝素治疗的严重并发症,其特点是血小板计数低和血栓形成风险增加。血尿素氮(BUN)作为肾功能和疾病严重程度的指标,在不同情况下与不良预后相关。然而,其与HIT死亡率的关系仍然知之甚少。我们的研究旨在探讨重症HIT患者的这种关系。方法采用2008 - 2019年MIMIC-IV 3.1数据库进行回顾性队列分析。通过ICD代码确定HIT患者。没有BUN数据或首次入住重症监护病房(ICU)的患者被排除在外。测量的主要结果是在多个时间点评估的全因死亡率。使用多变量Cox回归模型和Kaplan-Meier生存分析检验相关性。结果共纳入246例HIT患者,平均年龄66.2岁,男性占54.9%。BUN水平与住院期间(HR 1.01, 95% CI 1.01-1.02, p = 0.001)和30天内(HR 1.01, 95% CI 1.01-1.02, p p p p)的全因死亡率显著相关
{"title":"BUN and mortality in patients with heparin-induced thrombocytopenia: A retrospective cohort study.","authors":"Guang Tu, Zhonglan Cai, Guofeng Zhu, Min Huang","doi":"10.1177/00368504261420611","DOIUrl":"10.1177/00368504261420611","url":null,"abstract":"<p><p>IntroductionHeparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, characterized by low platelet counts and heightened thrombotic risk. Blood urea nitrogen (BUN), which serves as an indicator of both renal function and illness severity, has been associated with poor outcomes in different contexts. However, its association with mortality in HIT remains poorly understood. Our study aimed to explore this relationship in critically ill patients with HIT.MethodsThis study was a retrospective cohort analysis utilizing the MIMIC-IV 3.1 database from 2008 to 2019. Patients with HIT were pinpointed through ICD codes. Those without BUN data or whose intensive care unit (ICU) admission was not their first were excluded. The main outcome measured was all-cause mortality, evaluated at multiple time points. The associations were examined using multivariate Cox regression models and Kaplan-Meier survival analysis.ResultsThe research encompassed 246 individuals with HIT (average age 66.2 years, 54.9% male). BUN levels showed a significant association with all-cause mortality during the hospital stay (HR 1.01, 95% CI 1.01-1.02, <i>p</i> = 0.001), within 30 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001), within 90 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001), and within 365 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001). Quartile analysis revealed that the highest BUN quartile (Q4) was associated with the greatest mortality risk compared to the lowest quartile (Q1) at all time points. Kaplan-Meier and restricted cubic spline analyses corroborated these results, indicating a linear relationship between BUN and mortality.ConclusionElevated BUN levels were significantly associated with higher mortality rates among HIT patients in the ICU. Monitoring BUN levels may help identify patients at greater risk and inform clinical choices. Further research is warranted to elucidate the underlying mechanisms and possible treatments.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261420611"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146203906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of complications in open tracheostomy in patients taking low-dose aspirin. 小剂量阿司匹林开气管切开术并发症的比较。
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-01-16 DOI: 10.1177/00368504251412578
Thapthep Saowarot, Napadon Tangjaturonrasme

ObjectiveThe use of aspirin in patients undergoing open tracheostomy is an issue for which there is still no clear conclusion. This uncertainty leads surgeons to make decisions based on the risks and benefits of continuing versus discontinuing aspirin. Therefore, this study aims to investigate complications related to aspirin use. The primary outcome was bleeding complications, while other complications were secondary outcomes.MethodsThis was a retrospective study compiling data from patients who underwent open tracheostomy at the Department of Otolaryngology, Faculty of Medicine, Chulalongkorn university and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, between January 2019 and December 2023. Demographic data, medical conditions, indications for tracheostomy, surgeon characteristics, operative time, aspirin use status, and complications were reviewed.ResultsThere were 47 patients in total in this study: 15 patients in the aspirin continuation group and 32 patients in the aspirin discontinuation group. In the aspirin continuation group, there were no major or minor bleeding events. In the discontinuation group, there were two cases of major bleeding and two cases of minor bleeding (an incidence of 6.3% for each), although the differences observed were not statistically significant. There were no other complications that showed statistically significant differences between the two groups.ConclusionThis study has shown that low-dose aspirin (81 mg) does not increase the risk of bleeding or other complications in patients who undergo open tracheostomy. These results support that the continuation of aspirin may be safe in patients undergoing this procedure.

目的阿司匹林在气管切开患者中的应用是一个尚未有明确结论的问题。这种不确定性导致外科医生根据继续或停止服用阿司匹林的风险和收益做出决定。因此,本研究旨在调查阿司匹林使用相关的并发症。主要结局为出血并发症,其他并发症为次要结局。方法本研究是一项回顾性研究,收集了2019年1月至2023年12月期间在朱拉隆功大学医学院耳鼻喉科和泰国红十字会朱拉隆功国王纪念医院接受开放气管切开术的患者的数据。回顾了人口统计资料、医疗条件、气管切开术指征、外科医生特点、手术时间、阿司匹林使用情况和并发症。结果本研究共纳入47例患者,其中阿司匹林继续治疗组15例,停药组32例。在阿司匹林继续组中,没有发生大出血或小出血事件。停药组大出血2例,小出血2例(发生率分别为6.3%),差异无统计学意义。两组间无其他并发症,差异有统计学意义。结论:本研究表明,低剂量阿司匹林(81 mg)不会增加气管切开患者出血或其他并发症的风险。这些结果支持,继续服用阿司匹林可能是安全的。
{"title":"Comparison of complications in open tracheostomy in patients taking low-dose aspirin.","authors":"Thapthep Saowarot, Napadon Tangjaturonrasme","doi":"10.1177/00368504251412578","DOIUrl":"10.1177/00368504251412578","url":null,"abstract":"<p><p>ObjectiveThe use of aspirin in patients undergoing open tracheostomy is an issue for which there is still no clear conclusion. This uncertainty leads surgeons to make decisions based on the risks and benefits of continuing versus discontinuing aspirin. Therefore, this study aims to investigate complications related to aspirin use. The primary outcome was bleeding complications, while other complications were secondary outcomes.MethodsThis was a retrospective study compiling data from patients who underwent open tracheostomy at the Department of Otolaryngology, Faculty of Medicine, Chulalongkorn university and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, between January 2019 and December 2023. Demographic data, medical conditions, indications for tracheostomy, surgeon characteristics, operative time, aspirin use status, and complications were reviewed.ResultsThere were 47 patients in total in this study: 15 patients in the aspirin continuation group and 32 patients in the aspirin discontinuation group. In the aspirin continuation group, there were no major or minor bleeding events. In the discontinuation group, there were two cases of major bleeding and two cases of minor bleeding (an incidence of 6.3% for each), although the differences observed were not statistically significant. There were no other complications that showed statistically significant differences between the two groups.ConclusionThis study has shown that low-dose aspirin (81 mg) does not increase the risk of bleeding or other complications in patients who undergo open tracheostomy. These results support that the continuation of aspirin may be safe in patients undergoing this procedure.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251412578"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polypharmacy and potential drug-drug interactions among older patients: A cross-sectional baseline study pre-2023 Palestine crisis. 老年患者的多重用药和潜在的药物-药物相互作用:2023年前巴勒斯坦危机的横断面基线研究
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-02-11 DOI: 10.1177/00368504261423340
Rami Mosleh, Yazun Jarrar, Shurouq Ghalib Qadous, Mustafa Ghanim

ObjectivesPolypharmacy, the concurrent use of multiple medications, presents significant challenges and risks in modern healthcare systems, particularly among older individuals and those with chronic diseases. This study aimed to investigate the prevalence and determinants of potential drug-drug interactions (pDDIs) among older adults at Jerusalem, Gaza Strip, and the West Bank of Palestine. This study serves as a baseline assessment before the October 2023 Palestine crisis, which led to extensive forced displacement.MethodsThis cross-sectional study examined the prescribed medications for 403 participants, conducted between May 2023 and August 2023, 2 months prior to the invasion of Gaza. This study served as a baseline evaluation of the potential pDDIs before the 7 October 2023 of Palestine crisis. Participants recruited using simple random sampling technique from medical records' lists of patients. They were interviewed at various pharmacies and hospitals across Jerusalem, the Gaza Strip, and the West Bank of Palestine using an online questionnaire created via Google Forms. Descriptive, Univariate and multivariate analyses, and Chi-square tests were carried-out by SPSS v21.ResultsThe study revealed a high prevalence of pDDIs among the Palestinian population, with a substantial proportion of participants experiencing moderate to major interactions. Participants receiving a higher number of medications were significantly more likely to experience major pDDIs. Additionally, marital status was a significant factor associated with major pDDIs, with married individuals being more likely to experience major interactions compared to non-married individuals. Regional differences were also observed, with participants residing in the northern region of the West Bank more likely to experience moderate pDDIs. Moreover, participants diagnosed with dyslipidemia and diabetes mellitus were significantly more prone to moderate pDDIs.ConclusionsThese findings emphasize the interaction of clinical and demographic factors in influencing the risk of pDDIs among participant patients in Palestine. Healthcare providers should consider these factors when prescribing medications and designing interventions to reduce the risks associated with polypharmacy.

目的多重用药,即同时使用多种药物,在现代医疗保健系统中,特别是在老年人和慢性病患者中,提出了重大的挑战和风险。本研究旨在调查耶路撒冷、加沙地带和巴勒斯坦西岸老年人中潜在药物相互作用(pddi)的患病率和决定因素。这项研究是2023年10月巴勒斯坦危机之前的基线评估,该危机导致了广泛的被迫流离失所。方法本横断面研究检查了403名参与者的处方药,这些参与者于2023年5月至2023年8月(入侵加沙前2个月)进行。本研究作为2023年10月7日巴勒斯坦危机之前潜在发展中国家发展指标的基线评估。参与者采用简单的随机抽样技术从患者病历名单中招募。他们在耶路撒冷、加沙地带和巴勒斯坦西岸的各个药店和医院接受了采访,使用的是通过谷歌Forms创建的在线问卷。采用SPSS v21进行描述性、单因素和多因素分析及卡方检验。结果该研究揭示了巴勒斯坦人口中pddi的高患病率,相当大比例的参与者经历了中度到重度的互动。接受更多药物治疗的参与者更有可能经历严重的pddi。此外,婚姻状况是与主要pddi相关的重要因素,已婚个体比未婚个体更有可能经历主要的互动。还观察到区域差异,居住在西岸北部地区的参与者更有可能经历中度的pddi。此外,被诊断为血脂异常和糖尿病的参与者更容易出现中度pdi。结论这些研究结果强调了临床和人口因素在影响巴勒斯坦参与研究的患者发生pddi风险方面的相互作用。医疗保健提供者在开处方和设计干预措施以减少与多种用药相关的风险时应考虑这些因素。
{"title":"Polypharmacy and potential drug-drug interactions among older patients: A cross-sectional baseline study pre-2023 Palestine crisis.","authors":"Rami Mosleh, Yazun Jarrar, Shurouq Ghalib Qadous, Mustafa Ghanim","doi":"10.1177/00368504261423340","DOIUrl":"10.1177/00368504261423340","url":null,"abstract":"<p><p>ObjectivesPolypharmacy, the concurrent use of multiple medications, presents significant challenges and risks in modern healthcare systems, particularly among older individuals and those with chronic diseases. This study aimed to investigate the prevalence and determinants of potential drug-drug interactions (pDDIs) among older adults at Jerusalem, Gaza Strip, and the West Bank of Palestine. This study serves as a baseline assessment before the October 2023 Palestine crisis, which led to extensive forced displacement.MethodsThis cross-sectional study examined the prescribed medications for 403 participants, conducted between May 2023 and August 2023, 2 months prior to the invasion of Gaza. This study served as a baseline evaluation of the potential pDDIs before the 7 October 2023 of Palestine crisis. Participants recruited using simple random sampling technique from medical records' lists of patients. They were interviewed at various pharmacies and hospitals across Jerusalem, the Gaza Strip, and the West Bank of Palestine using an online questionnaire created via Google Forms. Descriptive, Univariate and multivariate analyses, and Chi-square tests were carried-out by SPSS v21.ResultsThe study revealed a high prevalence of pDDIs among the Palestinian population, with a substantial proportion of participants experiencing moderate to major interactions. Participants receiving a higher number of medications were significantly more likely to experience major pDDIs. Additionally, marital status was a significant factor associated with major pDDIs, with married individuals being more likely to experience major interactions compared to non-married individuals. Regional differences were also observed, with participants residing in the northern region of the West Bank more likely to experience moderate pDDIs. Moreover, participants diagnosed with dyslipidemia and diabetes mellitus were significantly more prone to moderate pDDIs.ConclusionsThese findings emphasize the interaction of clinical and demographic factors in influencing the risk of pDDIs among participant patients in Palestine. Healthcare providers should consider these factors when prescribing medications and designing interventions to reduce the risks associated with polypharmacy.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261423340"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of posterior wall acetabular fractures via the direct posterior approach using a seagull-shaped plate: A retrospective cohort study. 直接后路使用海鸥形钢板治疗髋臼后壁骨折:一项回顾性队列研究
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-01-09 DOI: 10.1177/00368504251413441
Shuaixian Tao, Yurong Zhao, Jidong Wang, Shaofeng Xu, Jifa Hou, Baoxin Li, Qiang Wang, Rong Ren, Zhonglin Lu, Zhaowei Li

ObjectiveTo evaluate the clinical efficacy of the direct posterior approach (DPA) with seagull-shaped plate fixation for treating posterior wall acetabular fractures.MethodsA retrospective cohort study of 17 patients (8 male, 9 female) with posterior wall acetabular fractures treated with DPA seagull-shaped plate fixation was conducted. Postoperative pelvic X-ray imaging and computed tomography were performed, and the quality of acetabular reduction was evaluated using the Matta score. The Merle d'Aubigné & Bone score, as modified by Matta, was used to assess hip joint function.ResultsThe mean ± standard deviation surgical incision length, operating time, and intraoperative blood loss were 9.7 ± 0.6 cm, 48.7 ± 9.1 min, and 235.3 ± 65.6 mL, respectively. According to the Matta score, 11 patients achieved excellent reduction quality, and six had good reduction quality, resulting in a 100% combined excellent or good reduction rate. All patients had good fracture healing, with a healing time of 9.7 ± 1.6 weeks. The modified Merle d'Aubigné & Bone score was 17.0 ± 1.6, with 11, 4, 2, and 0 patients rated as excellent, good, fair, and poor, respectively, yielding an 88.2% excellent or good outcome rate. Postoperative complications included fat liquefaction in one patient and deep vein thrombosis in the lower limbs of two patients, with an overall complication rate of 17.6%.ConclusionsDPA with seagull-shaped plate fixation provides satisfactory clinical outcomes for posterior wall acetabular fractures, improving patients' living ability and quality of life.

目的评价直接后路海鸥型钢板内固定治疗髋臼后壁骨折的临床疗效。方法对17例髋臼后壁骨折患者(男8例,女9例)采用DPA海鸥形钢板内固定进行回顾性队列研究。术后行盆腔x线成像和计算机断层扫描,使用Matta评分评估髋臼复位质量。经Matta修改的Merle d' aubign & Bone评分用于评估髋关节功能。结果手术切口长度、手术时间和术中出血量的平均±标准差分别为9.7±0.6 cm、48.7±9.1 min和235.3±65.6 mL。根据Matta评分,11例患者复位质量优良,6例复位质量良好,综合优良率为100%。所有患者骨折愈合良好,愈合时间为9.7±1.6周。改良的Merle d' aubign & Bone评分为17.0±1.6,分别有11例、4例、2例和0例患者被评为优、良、一般和差,优良率为88.2%。术后并发症1例脂肪液化,2例下肢深静脉血栓形成,总并发症发生率为17.6%。结论sdpa联合海鸥形钢板内固定治疗髋臼后壁骨折临床效果满意,提高了患者的生活能力和生活质量。
{"title":"Treatment of posterior wall acetabular fractures via the direct posterior approach using a seagull-shaped plate: A retrospective cohort study.","authors":"Shuaixian Tao, Yurong Zhao, Jidong Wang, Shaofeng Xu, Jifa Hou, Baoxin Li, Qiang Wang, Rong Ren, Zhonglin Lu, Zhaowei Li","doi":"10.1177/00368504251413441","DOIUrl":"10.1177/00368504251413441","url":null,"abstract":"<p><p>ObjectiveTo evaluate the clinical efficacy of the direct posterior approach (DPA) with seagull-shaped plate fixation for treating posterior wall acetabular fractures.MethodsA retrospective cohort study of 17 patients (8 male, 9 female) with posterior wall acetabular fractures treated with DPA seagull-shaped plate fixation was conducted. Postoperative pelvic X-ray imaging and computed tomography were performed, and the quality of acetabular reduction was evaluated using the Matta score. The Merle d'Aubigné & Bone score, as modified by Matta, was used to assess hip joint function.ResultsThe mean ± standard deviation surgical incision length, operating time, and intraoperative blood loss were 9.7 ± 0.6 cm, 48.7 ± 9.1 min, and 235.3 ± 65.6 mL, respectively. According to the Matta score, 11 patients achieved excellent reduction quality, and six had good reduction quality, resulting in a 100% combined excellent or good reduction rate. All patients had good fracture healing, with a healing time of 9.7 ± 1.6 weeks. The modified Merle d'Aubigné & Bone score was 17.0 ± 1.6, with 11, 4, 2, and 0 patients rated as excellent, good, fair, and poor, respectively, yielding an 88.2% excellent or good outcome rate. Postoperative complications included fat liquefaction in one patient and deep vein thrombosis in the lower limbs of two patients, with an overall complication rate of 17.6%.ConclusionsDPA with seagull-shaped plate fixation provides satisfactory clinical outcomes for posterior wall acetabular fractures, improving patients' living ability and quality of life.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251413441"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between N-terminal pro B-type natriuretic peptide and short- and long-term all-cause mortality in critically ill patients with sepsis: A retrospective study based on the Medical Information Mart for Intensive Care IV database. 危重症脓毒症患者n端前b型利钠肽与短期和长期全因死亡率的关系:基于重症监护医学信息市场IV数据库的回顾性研究
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2026-01-01 Epub Date: 2026-02-19 DOI: 10.1177/00368504261425535
Anke Shi, Haotian Lu, Jing Zhao, Mingshuai Ai, Jieqiong Yu, Tianpeng Hu, Shengtao Yan

BackgroundSepsis, caused by a dysregulated host response to infection, is a life-threatening condition linked to nearly one-fifth of deaths worldwide. As a biomarker of myocardial stress, N-terminal pro B-type natriuretic peptide (NT-proBNP) has gained attention for its potential association with clinical outcomes in sepsis patients. This study investigated its association with short- and long-term mortality in sepsis.MethodsThis retrospective observational cohort study utilized data from the Medical Information Mart for Intensive Care IV database. Sepsis patients on their first intensive care unit admission with NT-proBNP measured within 24 h were categorized into four groups based on their natural log-transformed levels. The primary endpoint was 30-day all-cause mortality (ACM), with secondary endpoints of 90-day and 1-year ACM. Cox models, Kaplan-Meier curves, restricted cubic splines (RCS), and subgroup analyses were performed to assess the relationship between log(NT-proBNP) and 30-day, 90-day, and 1-year ACM.ResultsThe study cohort consisted of 1237 patients, with 54.41% male. The 30-day, 90-day, and 1-year ACM rates were 27.41%, 29.99%, and 31.69%, respectively. Multivariate Cox analysis showed that log(NT-proBNP) was independently associated with higher risks of 30-day ACM (hazard ratio[HR] 1.12 [95% confidence interval (CI) 1.03-1.22]; P = 0.01), 90-day ACM (HR 1.12 [95% CI 1.03-1.22]; P = 0.005), and 1-year ACM (HR 1.11 [95% CI 1.03-1.20]; P = 0.007). These associations remained robust in sensitivity analyses. The RCS curves demonstrated a linear increase in ACM risk as log(NT-proBNP) levels rose. Subgroup analyses confirmed these associations across different patient groups.ConclusionElevated log(NT-proBNP) in critically ill sepsis patients are significantly and independently associated with higher 30-day, 90-day, and 1-year ACM, suggesting that NT-proBNP may serve as a valuable risk marker for both short- and long-term mortality in this population.

败血症是由宿主对感染反应失调引起的,是一种危及生命的疾病,与全球近五分之一的死亡有关。作为心肌应激的生物标志物,n端前b型利钠肽(NT-proBNP)因其与败血症患者临床结局的潜在关联而受到关注。本研究调查了其与脓毒症的短期和长期死亡率的关系。方法本回顾性观察队列研究利用重症监护医学信息市场IV数据库的数据。首次入住重症监护室的脓毒症患者在24小时内测量NT-proBNP,根据其自然对数转化水平将其分为四组。主要终点为30天全因死亡率(ACM),次要终点为90天和1年ACM。采用Cox模型、Kaplan-Meier曲线、限制性三次样条(RCS)和亚组分析来评估log(NT-proBNP)与30天、90天和1年ACM之间的关系。结果本研究共纳入1237例患者,男性占54.41%。30天、90天和1年的ACM利率分别为27.41%、29.99%和31.69%。多因素Cox分析显示,log(NT-proBNP)与30天ACM的高风险独立相关(风险比[HR] 1.12[95%可信区间(CI) 1.03-1.22];P = 0.01), 90天的ACM (HR 1.12 (95% CI 1.03 - -1.22); P = 0.005),和1年期ACM (HR 1.11 (95% CI 1.03 - -1.20); P = 0.007)。在敏感性分析中,这些关联仍然很强。RCS曲线显示,随着log(NT-proBNP)水平的升高,ACM风险呈线性增加。亚组分析证实了不同患者组之间的这些关联。结论:危重症脓毒症患者的log升高(NT-proBNP)与30天、90天和1年的ACM升高有显著且独立的相关性,表明NT-proBNP可能是该人群短期和长期死亡率的有价值的风险标志物。
{"title":"Association between N-terminal pro B-type natriuretic peptide and short- and long-term all-cause mortality in critically ill patients with sepsis: A retrospective study based on the Medical Information Mart for Intensive Care IV database.","authors":"Anke Shi, Haotian Lu, Jing Zhao, Mingshuai Ai, Jieqiong Yu, Tianpeng Hu, Shengtao Yan","doi":"10.1177/00368504261425535","DOIUrl":"10.1177/00368504261425535","url":null,"abstract":"<p><p>BackgroundSepsis, caused by a dysregulated host response to infection, is a life-threatening condition linked to nearly one-fifth of deaths worldwide. As a biomarker of myocardial stress, N-terminal pro B-type natriuretic peptide (NT-proBNP) has gained attention for its potential association with clinical outcomes in sepsis patients. This study investigated its association with short- and long-term mortality in sepsis.MethodsThis retrospective observational cohort study utilized data from the Medical Information Mart for Intensive Care IV database. Sepsis patients on their first intensive care unit admission with NT-proBNP measured within 24 h were categorized into four groups based on their natural log-transformed levels. The primary endpoint was 30-day all-cause mortality (ACM), with secondary endpoints of 90-day and 1-year ACM. Cox models, Kaplan-Meier curves, restricted cubic splines (RCS), and subgroup analyses were performed to assess the relationship between log(NT-proBNP) and 30-day, 90-day, and 1-year ACM.ResultsThe study cohort consisted of 1237 patients, with 54.41% male. The 30-day, 90-day, and 1-year ACM rates were 27.41%, 29.99%, and 31.69%, respectively. Multivariate Cox analysis showed that log(NT-proBNP) was independently associated with higher risks of 30-day ACM (hazard ratio[HR] 1.12 [95% confidence interval (CI) 1.03-1.22]; <i>P</i> = 0.01), 90-day ACM (HR 1.12 [95% CI 1.03-1.22]; <i>P</i> = 0.005), and 1-year ACM (HR 1.11 [95% CI 1.03-1.20]; <i>P</i> = 0.007). These associations remained robust in sensitivity analyses. The RCS curves demonstrated a linear increase in ACM risk as log(NT-proBNP) levels rose. Subgroup analyses confirmed these associations across different patient groups.ConclusionElevated log(NT-proBNP) in critically ill sepsis patients are significantly and independently associated with higher 30-day, 90-day, and 1-year ACM, suggesting that NT-proBNP may serve as a valuable risk marker for both short- and long-term mortality in this population.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261425535"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12924985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146229833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of dental guards in reducing incisor injuries during direct laryngoscopy: A retrospective comparative clinical study. 护齿器在直接喉镜检查中减少门牙损伤的有效性:回顾性比较临床研究。
IF 2.9 4区 综合性期刊 Q2 MULTIDISCIPLINARY SCIENCES Pub Date : 2025-10-01 Epub Date: 2025-11-20 DOI: 10.1177/00368504251400808
Ziyue Li, Haolai Pan, Xinlong Huang, Shaoxiao Li, Siwen Xia, Huixia Huang

ObjectiveTo evaluate the effectiveness of dental guards in preventing incisor injuries during direct laryngoscopy in microlaryngeal surgery (MLS).Study designNonrandomized retrospective comparative study.MethodsBetween 2022 and 2024, 50 patients who underwent elective MLS using a dental guard were consecutively selected as the dental guard group, and another 50 patients who underwent surgery without a dental guard were selected as the control group. A standardized silicone dental guard was applied to the maxillary incisors of the experimental group. An independent dentist conducted postoperative dental evaluations to assess incisor mobility and enamel damage.ResultsThe experimental group demonstrated significantly lower rates of dental injury (2% vs. 20%) compared with those of the control group. No adverse events related to dental guard use were reported.ConclusionDental guards effectively reduced the incidence of incisor injuries during direct laryngoscopy. Routine use is recommended to minimize perioperative dental complications.

目的评价牙护套在喉外科直接喉镜检查中预防切牙损伤的效果。研究设计:非随机回顾性比较研究。方法选取2022 - 2024年期间50例使用牙护罩行选择性MLS手术的患者作为牙护组,50例不使用牙护罩行选择性MLS手术的患者作为对照组。实验组上颌门牙采用标准化硅胶护牙套。一位独立的牙医进行了术后牙齿评估,以评估门牙的活动能力和牙釉质损伤。结果实验组的牙损伤率明显低于对照组(2% vs. 20%)。未见与牙护套使用相关的不良事件报告。结论护齿器可有效降低直接喉镜检查中门牙损伤的发生率。建议常规使用,以尽量减少围手术期牙科并发症。
{"title":"Effectiveness of dental guards in reducing incisor injuries during direct laryngoscopy: A retrospective comparative clinical study.","authors":"Ziyue Li, Haolai Pan, Xinlong Huang, Shaoxiao Li, Siwen Xia, Huixia Huang","doi":"10.1177/00368504251400808","DOIUrl":"10.1177/00368504251400808","url":null,"abstract":"<p><p>ObjectiveTo evaluate the effectiveness of dental guards in preventing incisor injuries during direct laryngoscopy in microlaryngeal surgery (MLS).Study designNonrandomized retrospective comparative study.MethodsBetween 2022 and 2024, 50 patients who underwent elective MLS using a dental guard were consecutively selected as the dental guard group, and another 50 patients who underwent surgery without a dental guard were selected as the control group. A standardized silicone dental guard was applied to the maxillary incisors of the experimental group. An independent dentist conducted postoperative dental evaluations to assess incisor mobility and enamel damage.ResultsThe experimental group demonstrated significantly lower rates of dental injury (2% vs. 20%) compared with those of the control group. No adverse events related to dental guard use were reported.ConclusionDental guards effectively reduced the incidence of incisor injuries during direct laryngoscopy. Routine use is recommended to minimize perioperative dental complications.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"108 4","pages":"368504251400808"},"PeriodicalIF":2.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12639199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Science Progress
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1